Study links circadian rhythm disruption to obesity and diabetes

FHS
July 18, 2024
3:50 am

Disruption of circadian rhythms and clock gene expression is linked to adverse metabolic health outcomes, including obesity and diabetes. Further research is needed to understand these relationships and their implications for treatment and prevention.

Researchers reveal unique characteristics of previously unexplored protein FAM110A

An international research collaboration, led by Prof. Dr. Robert Grosse (Centre for Integrative Biological Signalling Studies and Institute of Clinical and Experimental Pharmacology and Toxicology,

July 16, 2024

Getting abortion pills through the mail is safe, quick, and effective, study finds

Amid a national furor over access to abortion, a new study found that dispensing abortion pills though mail-order pharmacies worked as effectively as requiring patients

May 15, 2024

In Friday IPO doubleheader, Apogee and Sagimet help crack open a stuck window on Wall Street

Mark Friday, July 14, in biotech’s 2023 yearbook. Two drug developers, Apogee Therapeutics and Sagimet Biosciences, will join the Nasdaq in upsized offerings, a positive

July 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.